The medication suppresses thirst signals while simultaneously causing potential fluid loss through gastrointestinal side effects
Elevated plasma TMAO concentrations predict incident CVD risks in multiple clinical cohorts (47, 914), and both animal models with microbial transplantation (4, 15) and various studies on mice and humans with raised TMAO have revealed mechanistic and prognostic links between microbial TMAO production and both atherosclerosis and thrombosis, as well as chronic kidney disease and heart failure (46, 12, 13, 1618)
Topical applications appear generally well-tolerated in small studies, but systemic safety, long-term effects, and drug interactions remain inadequately characterized
Dali R, Estrada-Meza J, Langlet F
There are three Wegovy injection sites to which you can inject the medication: the stomach, thigh, and upper arm
Athletes subject to drug testing should be aware that use could result in positive tests and associated consequences